We show cross-presentation by Vγ9Vδ2 T cells for three different tumor antigens; gp100, MART1 and MAGE-A3, as long peptide or recombinant protein and restricted by two different HLA molecules (Figure 4). Here, PMEL is linked to neoplasm.